AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Medistim

Earnings Release • Oct 24, 2019

3662_rns_2019-10-24_5054bac2-2518-4c8c-af85-5f2d52fc25de.html

Earnings Release

Open in Viewer

Opens in native device viewer

Results for Medistim ASA as of the 3rd quarter 2019

Sales ended at MNOK 85.5 for the quarter (MNOK 77.6), a 10.2 % growth. Sales as of September increased by 17.6 % and ended at MOK 268.1 (MNOK 228.0). Revenue from own products showed a currency neutral increase of 15.9 % for the quarter and a currency neutral growth of 18.8 % YTD. There has been a solid growth in sales of combined ultrasound imaging and flow systems. Number of systems sold or leased increased with 107 % for the quarter and with 77 % year to date. Operating profit (EBIT) for the quarter ended at MNOK 19.1 (MNOK 14.5). Operating profit as of September ended at MNOK 70.0 (MNOK 46.2). MiraQ, Medistims newst product that combines flow measurement and ultrasound imaging, was cleared for sales in Japan during the quarter.